Skip to main content
Log in

Grundlagen der Gerinnungsdiagnostik (Thrombophilieabklärung)

Principles of coagulation diagnostics (thrombophilia testing)

  • Leitthema
  • Published:
Gynäkologische Endokrinologie Aims and scope

Zusammenfassung

Eine Thrombophilieabklärung umfasst die Suche nach hereditären und erworbenen Thrombophilien. Zur ersten Kategorie gehören die Faktor-V-Leiden-Mutation, die Prothrombinmutation, der hereditäre Antithrombin‑, Protein-C- und Protein-S-Mangel sowie bestimmte kongenitale Dysfibrinogenämien. Der Stellenwert hereditärer Thrombophilien als Risikomarker für Rezidivthrombosen ist gering. Zur zweiten Kategorie gehören das Antiphospholipidantikörpersyndrom, myeloproliferative Neoplasien und die paroxysmale nächtliche Hämoglobinurie. Die Durchführung der Laboruntersuchung und die Bewertung ihrer Befunde erfordern die korrekte Indikationsstellung, die Wahl des geeigneten Zeitpunkts und die Berücksichtigung von klinischen Umständen und präanalytischen Einflüssen.

Abstract

A laboratory investigation of thrombophilia comprises hereditary and acquired laboratory markers. The first category includes the factor V Leiden mutation, prothrombin mutation, hereditary antithrombin deficiency, protein C deficiency, protein S deficiency and certain congenital dysfibrinogenemias; however, hereditary thrombophilias are of little value as indicators of an elevated risk of recurrent thrombosis. The second category of acquired thrombophilia includes antiphospholipid antibody syndrome, myeloproliferative neoplasms and paroxysmal nocturnal hemoglobinuria. The correct indications and timing of the investigation as well as consideration of the clinical circumstances and preanalytical influencing factors are of major importance for a valid interpretation of laboratory results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Baglin T (2013) The role of the laboratory in treatment with new oral anticoagulants. J Thromb Haemost 11(Suppl 1):122–128

    Article  PubMed  Google Scholar 

  2. Baglin T, Douketis J, Tosetto A, Marcucci M, Cushman M, Kyrle P, Palareti G, Poli D, Tait RC, Iorio A (2010) Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost 8:2436–2442

    Article  CAS  PubMed  Google Scholar 

  3. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, Mackie I, Makris M, Nokes T, Perry D, Tait RC, Walker I, Watson H (2010) Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 149:209–220

    Article  PubMed  Google Scholar 

  4. Baglin T, Luddington R, Brown K, Baglin C (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: Prospective cohort study. Lancet 362:523–526

    Article  PubMed  Google Scholar 

  5. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293:2352–2361

    Article  CAS  PubMed  Google Scholar 

  6. Christiansen SC, Lijfering WM, Helmerhorst FM, Rosendaal FR, Cannegieter SC (2010) Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event. J Thromb Haemost 8:2195–2168

    Article  Google Scholar 

  7. Cohn DM, Vansenne F, de Borgie CA, Middeldorp S (2012) Thrombophilia testing for prevention of recurrent venous thromboembolism. Cochrane Database Syst Rev 12:CD7069

    PubMed  Google Scholar 

  8. Coppola A, Tufano A, Cerbone AM, Di Minno G (2009) Inherited thrombophilia: Implications for prevention and treatment of venous thromboembolism. Semin Thromb Hemost 35:683–694

    Article  CAS  PubMed  Google Scholar 

  9. De Stefano V, Rossi E (2013) Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. Thromb Haemost 110:697–705

    Article  CAS  PubMed  Google Scholar 

  10. De Stefano V, Ruggeri M, Cervantes F, Alvarez-Larrán A, Iurlo A, Randi ML, Elli E, Finazzi MC, Finazzi G, Zetterberg E, Vianelli N, Gaidano G, Rossi E, Betti S, Nichele I, Cattaneo D, Palova M, Ellis MH, Cacciola R, Tieghi A, Hernandez-Boluda JC, Pungolino E, Specchia G, Rapezzi D, Forcina A, Musolino C, Carobbio A, Griesshammer M, Sant’Antonio E, Vannucchi AM, Barbui T (2016) High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists. Leukemia 30:2032–2038

    Article  CAS  PubMed  Google Scholar 

  11. De Stefano V, Qi X, Betti S, Rossi E (2016) Splanchnic vein thrombosis and myeloproliferative neoplasms: Molecular-driven diagnosis and long-term treatment. Thromb Haemost 115:240–249

    Article  PubMed  Google Scholar 

  12. Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P (2007) The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med 147:766–747

    Article  PubMed  Google Scholar 

  13. Favaloro EJ, McDonald D, Lippi G (2009) Laboratory investigation of thrombophilia: The good, the bad, and the ugly. Semin Thromb Hemost 35:695–710

    Article  CAS  PubMed  Google Scholar 

  14. Favaloro EJ, Mohammed S, Curnow J, Pasalic L (2019) Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): Potential for false positives and false negatives. Pathology 51:292–300

    Article  CAS  PubMed  Google Scholar 

  15. Gosselin RC, Adcock DM (2016) The laboratory’s 2015 perspective on direct oral anticoagulant testing. J Thromb Haemost 14:886–893

    Article  CAS  PubMed  Google Scholar 

  16. Graham N, Rashiq H, Hunt BJ (2014) Testing for thrombophilia: Clinical update. Br J Gen Pract 64:e120–e122

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hill A, Kelly RJ, Hillmen P (2013) Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 121:4985–4996

    Article  CAS  PubMed  Google Scholar 

  18. Kyrle PA, Rosendaal FR, Eichinger S (2010) Risk assessment for recurrent venous thrombosis. Lancet 376:2032–2039

    Article  PubMed  Google Scholar 

  19. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S (2004) The risk of recurrent venous thromboembolism in men and women. N Engl J Med 350:2558–2563

    Article  CAS  PubMed  Google Scholar 

  20. Landolfi R, Di Gennaro L, Falanga A (2008) Thrombosis in myeloproliferative disorders: Pathogenetic facts and speculation. Leukemia 22:2020–2028

    Article  PubMed  Google Scholar 

  21. Lindhoff-Last E, Luxembourg B (2008) Evidence-based indications for thrombophilia screening. Vasa 37:19–30

    Article  CAS  PubMed  Google Scholar 

  22. Linnemann B, Hart C (2019) Laboratory diagnostics in thrombophilia. Hamostaseologie 39:49–61

    Article  PubMed  Google Scholar 

  23. Merriman L, Greaves M (2006) Testing for thrombophilia: An evidence-based approach. Postgrad Med J 82:699–704

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306

    Article  CAS  PubMed  Google Scholar 

  25. Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N, Testa S, Marongiu F, Bison E, Denas G, Banzato A, Padayattil JS, Iliceto S (2011) Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: A multicenter prospective study. Blood 118:4714–4718

    Article  CAS  PubMed  Google Scholar 

  26. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A (2007) The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 92:199–205

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jan-Dirk Studt.

Ethics declarations

Interessenkonflikt

J.-D. Studt gibt an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Redaktion

B. Imthurn, Zürich

B. Toth, Innsbruck

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Studt, JD. Grundlagen der Gerinnungsdiagnostik (Thrombophilieabklärung). Gynäkologische Endokrinologie 17, 129–133 (2019). https://doi.org/10.1007/s10304-019-0264-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10304-019-0264-9

Schlüsselwörter

Keywords

Navigation